Cmax | The maximum observed arithmetic mean conc. of T3 measured after dosing. |
Cmax/D | The Cmax divided by the dose administered. |
Tmax | The time after dosing at which the maximum observed arithmetic mean conc. of T3 was observed. |
AUC(0–t) | The area under the T3 arithmetic mean conc. vs. time curve from time zero the time after dosing at which the last quantifiable concentration of the drug was observed estimated by the linear or linear/log trapezoidal method. |
AUC(0–t)/D | The AUC(0–t) divided by the dose administered. |
When data permitted, the slope of the terminal elimination phase of each arithmetic mean concentration vs. time curve was determined by log-linear regression, and the following additional parameters were estimated: |
Additional parameters estimated |
Parameter | Description of Parameter |
t1/2 | The apparent terminal elimination half-life. |
AUC(0–inf) | The area under the arithmetic mean concentration vs. time curve from time zero to infinity. |
AUC(0–inf)/D | AUC(0–inf) divided by the dose administered. |
CL | Clearance: the apparent volume of plasma cleared of T3 per unit time after intravenous dosing. |
Vd | The apparent volume of distribution of T3, determined from the terminal elimination phase after intravenous dosing. |